Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BC.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BC.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
BC.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
BC.2SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
BC.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BC.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-18441.9South Korea
BC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
BC.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BC.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
BC.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BC.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BC.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BC.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BC.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
BC.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BC.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BC.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BC.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BC.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BC.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-18248.7Germany
BC.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BC.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BC.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BC.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BC.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BC.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BC.2ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
BC.2ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
BC.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
BC.2ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
BC.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BC.2ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BC.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BC.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BC.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
BC.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
BC.2SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
BC.2SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used